Gastroenteropancreatic Neuroendocrine Tumors. Ten Year Experience at Instituto Oncologico Nacional. Panama 2004-2015.

#1384

Introduction: Gastroenteropancreatic neuroendocrine tumours (GEP-NET) are rare neoplasm with a rising incidence worldwide.

Aim(s): The aim of this study was to analyze demographic, tumor, therapy, and clinical outcomes of patients presenting with GEP-NET in our institution

Materials and methods: The cases of 152 patients with histological proven GEP-NET evaluated between 2004 and 2015 were reviewed retrospectively.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Castillo-Fernandez O, Vergara R, Moreno-Ríos J, Cukier M, Tapia H,

Keywords: grade, prognosis, neuroendocrine tumor,

To read the full abstract, please log into your ENETS Member account.